JOLT Health Inc. Announces Issuance of Common Shares in Satisfaction of Interest Payments to Promissory Note Holders and Interest Payment to Convertible Debenture Holder VANCOUVER, BC, CANADA, May 25, 2023 (GLOBE NEWSWIRE) -- Jolt Health Inc. (formerly Love Pharma Inc.) (“Jolt” and or “the Company”) (CSE:JOLT) (FSE: G1Q0)  is pleased to announce that pursuant to a...

LOVE PHARMA INC. ANNOUNCES CHANGE OF NAME TO “JOLT HEALTH INC.” AND INCREASED FOCUS ON BIOTECHNOLOGY VANCOUVER, BC, CANADA, May 16, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0)  is pleased to announce that it has changed its name to “Jolt Health...

LOVE PHARMA TO EVALUATE MINING OPPORTUNITIES VANCOUVER, BC, CANADA, April 05, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is currently evaluating mining opportunities in the battery component...

LOVE PHARM INC. ANNOUNCES GRANT OF STOCK OPTIONS VANCOUVER, BC, CANADA, April 03, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0)  is pleased to announce that it has issued a total of 5,035,000 options...